Davis's Drug Guide
ocrelizumab/hyaluronidase
General
Pronunciation:
ok-re-liz-ue-mab/hye-al-yoor-on-i-dase
Trade Name(s)
- Ocrevus Zunovo
Ther. Class.
anti-multiple sclerosis agents
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Ocrelizumab/hyaluronidase." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. www.drugguide.com/ddo/view/Davis-Drug-Guide/3580136/all/ocrelizumab_hyaluronidase.
Vallerand AHA, Sanoski CAC, . Ocrelizumab/hyaluronidase. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580136/all/ocrelizumab_hyaluronidase. Accessed April 20, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Ocrelizumab/hyaluronidase. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580136/all/ocrelizumab_hyaluronidase
Vallerand AHA, Sanoski CAC, . Ocrelizumab/hyaluronidase [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 April 20]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580136/all/ocrelizumab_hyaluronidase.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - ocrelizumab/hyaluronidase
ID - 3580136
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580136/all/ocrelizumab_hyaluronidase
PB - F.A. Davis Company
ET - 19
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -